Literature DB >> 10609899

Total arterial coronary revascularization and factors influencing in-hospital mortality.

A G Royse1, C F Royse, J Tatoulis.   

Abstract

OBJECTIVE: To determine if arterial conduit selection or more efficient arterial revascularization techniques influence in-hospital mortality.
METHODS: Data from patients undergoing coronary artery bypass surgery at Royal Melbourne Hospital, Australia, between 1 January 1996 and 30 June 1998 (n = 1681) was collected prospectively. Logistic regression analysis was performed.
RESULTS: Independent preoperative predictors of increased in-hospital mortality included renal failure, redo coronary artery surgery and intra-aortic balloon pump use. In-hospital mortality for total arterial revascularization 0.7%, radial artery use 0.9%, pedicled arterial revascularization 0.2%, composite arterial conduit 0.4%, and the exclusive Y graft operation 0.3%. These were all associated with reduced in-hospital mortality. Mortality when vein graft was used was 2.9%. Most patients received total arterial revascularization, which was considered the primary surgical strategy.
CONCLUSION: Total arterial revascularization, radial artery use and complex arterial reconstructions were associated with reduced in-hospital mortality. Preoperative renal failure, intra-aortic balloon pump use and redo coronary surgery predicted greater in-hospital mortality.

Entities:  

Mesh:

Year:  1999        PMID: 10609899     DOI: 10.1016/s1010-7940(99)00306-1

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  2 in total

1.  Total arterial revascularisation in left ventricular dysfunction.

Authors:  Yongzhi Deng; Zongquan Sun; Hugh S Paterson
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2006

2.  The effect of total arterial grafting on medium-term outcomes following coronary artery bypass grafting.

Authors:  Jean-Francois Légaré; Ansar Hassan; Karen J Buth; John A Sullivan
Journal:  J Cardiothorac Surg       Date:  2007-10-23       Impact factor: 1.637

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.